Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
DuncanSLobleyGHoltropGInceJJohnstoneALouisPet alHuman colonic microbiota associated with diet, obesity and weight loss
It is not held on the MHRA register of products with a marketing authorisation and is not approved for any therapeutic indication
Hello, I am Doctor Prasoon
R Clinical implications of slow acetylation: Increased risk of isoniazid-induced hepatotoxicity and peripheral neuropathy (tuberculosis treatment) R Increased risk of sulfonamide hypersensitivity reactions R Increased risk of aromatic amine-related bladder cancer in occupational exposure settings (dye workers, rubber industry) R Drug-induced lupus from hydralazine and procainamide occurs almost exclusively in slow acetylators R Altered caffeine metabolism (slow acetylators clear caffeine more slowly via the NAT2 pathway) R NAT1 polymorphisms are less well characterized but the slow allele NAT1*14 has been associated with increased risk of cancers from dietary aromatic amines
Free sampling policy
US$ 24.59
US$ 23.19
US$ 23.28
US$ 25.66
US$ 20.01
US$ 28.71
US$ 27.82
US$ 19.98
US$ 22.77
US$ 22.08
